The C-174G promoter polymorphism of the IL-6 gene has been established to control transcriptional regulation [10] and has been associated with plasma IL-6 levels in patients with systemic-onset juvenile chronic arthritis and in patients with primary Sjögren’s syndrome [11]. The gene discussed is IL6; the disease is juvenile idiopathic arthritis.